2021-2022 Interim
Meeting Details 01/11/2022 2:30 PM, Remote B
Amendments
No proposed amendments are available for this meeting.
Meeting Materials
| Document Type | Measure | Exhibit Title | Submitter | |
|---|---|---|---|---|
| Meeting Material | LC0032_DRAFT_2022_Regular_Session | staff | ||
| Meeting Material | LC0034_DRAFT_2022_Regular_Session | staff | ||
| Meeting Material | LC0035_DRAFT_2022_Regular_Session | staff | ||
| Meeting Material | LC0097_DRAFT_2022_Regular_Session | staff | ||
| Meeting Material | COVID-19 Update - Fariborz Pakseresht (presentation) | Fariborz Pakseresht, Director, Oregon Department of Human Services | ||
| Meeting Material | COVID-19 Update - Patrick Allen (presentation) | Patrick Allen, Director, Oregon Health Authority | ||
| Meeting Material | Introduction of Committee Legislative Concepts - staff (LC0097 OHA recommendation) | staff | ||
| Meeting Material | Introduction of Committee Legislative Concepts - staff (Summary of Committee Legislative Concepts) | staff | ||
| Meeting Material | Medicaid Waiver Renewal - Anna Bar (comments) | Anna Bar, President, Oregon Dermatology Society | ||
| Meeting Material | Medicaid Waiver Renewal - Jeremy Vandehey and Dana Hittle (presentation) | Jeremy Vandehey and Dana Hittle, Oregon Health Authority | ||
| Meeting Material | Prescription Drug Prices - Jesse O'Brien (Prescription Drug Price Transparency annual report) | Jesse O'Brien, Department of Consumer and Business Services | ||
| Meeting Material | Prescription Drug Prices - Jesse O'Brien (presentation) | Jesse O'Brien, Department of Consumer and Business Services | ||
| Meeting Material | Prescription Drug Prices - Kai Yeung (presentation) | Kai Yeung Assistant Scientific Investigator, Kaiser Permanente Washington Health Research Institute |